Global Prostate Biopsy Devices Market Size, Competition Landscape and Supply Chain Research Report 2025

Research Summary

Prostate biopsy devices are medical instruments designed for the collection of tissue samples from the prostate gland for diagnostic purposes. A prostate biopsy is typically performed when there are concerns about prostate cancer based on elevated levels of prostate-specific antigen (PSA) or abnormal findings during a digital rectal examination. The devices commonly used for prostate biopsies include biopsy needles, guidance systems such as transrectal ultrasound (TRUS), and sometimes MRI-guided systems. During the procedure, the biopsy needle is guided through the rectum to reach the prostate, and small tissue samples are collected for examination under a microscope. These devices are crucial for obtaining accurate and representative tissue samples to determine the presence of cancer cells and assess the grade and extent of prostate cancer, aiding in the diagnosis and subsequent treatment planning for patients with suspected prostate cancer. Advances in technology and imaging techniques continue to refine and improve the precision of prostate biopsy devices, enhancing diagnostic accuracy and reducing patient discomfort.

According to WENKH research statistics, the global Prostate Biopsy Devices market size will reach 673.12 Million USD in 2025 and is projected to reach 956.02 Million USD by 2032, with a CAGR of 5.14% (2025-2032). Among them, the Asia-Pacific Prostate Biopsy Devices market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.

The global Prostate Biopsy Devices market is highly competitive, with key market players including BD, Argon Medical Devices, Invivo, Cook Medical, TSK, UROMED, Biomedical, Amecath, Sterylab, Geotekmedical, etc. This report categorizes the competitive landscape of the global Prostate Biopsy Devices market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Prostate Biopsy Devices market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Prostate Biopsy Devices industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Prostate Biopsy Devices and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Prostate Biopsy Devices in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Prostate Biopsy Devices market. By considering local policies, this report evaluates the market prospects of Prostate Biopsy Devices in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

BD

Argon Medical Devices

Invivo

Cook Medical

TSK

UROMED

Biomedical

Amecath

Sterylab

Geotekmedical

Product Segment

Reusable Devices

Disposable Devices

Product Application

Hospitals

Ambulatory Surgical Center (ASCs)

Diagnostic Centers

Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Prostate Biopsy Devices Industry Chain Analysis

Chapter 3: Global Prostate Biopsy Devices Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Prostate Biopsy Devices Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Prostate Biopsy Devices Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Prostate Biopsy Devices Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source

Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.